BioPharmSignal logoBioPharmSignal

Biotech News

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

Apyx Medical (APYX)Apyx MedicalEarnings

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body Contouring System ™ (AYON), today reported financial results for its third quarter ended September 30, 2026.

Related news

APYXApyx Medical2026-10-22 12:00 EST

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

TMCITreace Medical Concepts2026-11-06 12:05 EST

Treace Medical Concepts Reports Third Quarter 2026 Financial Results

CVRXCVRx2026-11-05 21:05 EST

CVRx Reports Third Quarter 2026 Financial and Operating Results

AORTArtivion2026-11-05 21:05 EST

Artivion Reports Third Quarter 2026 Financial Results

PLSEPulse Biosciences2026-11-05 21:05 EST

Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results

SGHTSight Sciences2026-11-04 21:05 EST

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

ADPTAdaptive Biotechnologies2026-11-04 21:05 EST

Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results

PRCTPROCEPT BioRobotics2026-11-04 21:05 EST

PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

ACHCAcadia Healthcare2026-11-04 21:05 EST

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance

ICUSeaStar Medical2026-11-04 13:41 EST

SeaStar Medical to Report Third Quarter Financial Results on November 11, 2026

View all latest news

Apyx Medical

Surgical Aesthetics Apyx Medical develops energy-based systems used in cosmetic and surgical procedures. Its technology is intended to contract soft tissue and support body-contouring outcomes. Renuvion Renuvion combines helium plasma with radiofrequency energy for precise delivery beneath the skin. The platform is used by plastic and...

Recent company news

APYXApyx Medical2026-11-05 12:00 EST

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

APYXApyx Medical2026-10-22 12:00 EST

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

APYXApyx Medical2026-10-21 12:00 EST

Apyx Medical Corporation to Participate in Upcoming Investor Conferences

APYXApyx Medical2026-09-29 12:00 EST

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

APYXApyx Medical2026-08-06 20:05 EST

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

Stock data

Close
3.06 USD
Market cap
161.21M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States